Why did XCX.CN stock fall 50% today?

XCX.CN stock fell **50.00%** due to thin liquidity, a large sell execution and weak fundamentals. Volume spiked to **718,971** shares versus average **21,026**, amplifying downward moves and slippage.

What are realistic price targets for XCX.CN stock?

Short‑term resistance sits near **C$0.01**, medium‑term recovery **C$0.02**, and downside stress floor **C$0.002**. Targets assume improved liquidity and positive operational updates.

How does Meyka AI rate XCX.CN stock?

Meyka AI rates XCX.CN with a score out of 100: **65.10**, Grade **B**, suggestion **HOLD**. The grade factors benchmark, sector performance, growth and analyst consensus and is informational only.

Is XCX.CN stock a safe long‑term hold?

No. XCX.CN stock shows weak balance sheet metrics, negative EPS and extreme volatility. Long‑term holders should wait for revenue growth and stronger financials before considering exposure.

CA Stocks

XCX.CN falls 50% to C$0.005 on CNQ Feb 13, 2026: selling pressure ahead

ByHuzaifa Zahoor February 13, 2026

The XCX.CN stock plunged 50.00% to C$0.005 on the CNQ (Canada) during market hours on Feb 13, 2026, on a 718,971 share print versus an average of 21,026. Today’s move erased the previous close of C$0.01 and left the share price at the year low. The drop reflects thin liquidity, negative fundamentals and high short-term volatility in Greenrise Global Brands Inc. (XCX.CN), a Canadian healthcare firm supplying medical cannabis products to German pharmacies.